PMID- 12642003
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 1523-3847 (Print)
IS  - 1523-3847 (Linking)
VI  - 5
IP  - 2
DP  - 2003 Apr
TI  - Type-specific Serologic Testing for Herpes Simplex Virus-2.
PG  - 159-165
AB  - Genital herpes due to infection with herpes simplex virus-2 (HSV-2) affects an 
      estimated 60 million adults in the United States. Over 90% are unaware of their 
      infection but are at risk of transmitting HSV to partners. This ongoing "silent" 
      disease is responsible for the continued increase in HSV prevalence. The recent 
      advent of type-specific serologic tests has allowed accurate differentiation of 
      HSV-1 and HSV-2 infection. Screening of at-risk populations will allow 
      identification of individuals with genital herpes and provide an opportunity for 
      risk reduction counseling and interventions to reduce transmission.
FAU - Leone, Peter
AU  - Leone P
AD  - University of North Carolina, Department of Infectious Diseases, CB # 7030, 547 
      Burnett - Womac IC, Chapel Hill, NC 27599-7030, USA. pal007@med.unc.edu
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Curr Infect Dis Rep
JT  - Current infectious disease reports
JID - 100888983
EDAT- 2003/03/19 04:00
MHDA- 2003/03/19 04:01
CRDT- 2003/03/19 04:00
PHST- 2003/03/19 04:00 [pubmed]
PHST- 2003/03/19 04:01 [medline]
PHST- 2003/03/19 04:00 [entrez]
AID - 10.1007/s11908-003-0053-3 [doi]
PST - ppublish
SO  - Curr Infect Dis Rep. 2003 Apr;5(2):159-165. doi: 10.1007/s11908-003-0053-3.